 GSKs price might have underwhelmed recently, but its picking up now, calling for a closer look at it after a demerger with its consumer healthcare division last quarter. Its largely well placed to face macroeconomic pressures of slow growth, high inflation, and rising interest rates with strong margins and muted debt. 